Strategies for Diagnosis and Prevention of Venous Thromboembolism During Pregnancy

Overview

Journal J Pregnancy

Publisher Wiley

Specialty Gynecology & Obstetrics

Date 2011 Aug 27

PMID 21869932

Citations 6

Authors

Shalini Jain Bagaria

V B Bagaria

Affiliations

Soon will be listed here.

Abstract

Pregnancy and the postpartum period have an increased incidence of venous thromboembolism (VTE). The condition is unique during this period for several reasons. Primarily, because there is complexity in diagnosing this condition in view of altered physiology and preexisting edema in pregnancy and also because there are restrictions on the use of certain drugs and a need for vigilant monitoring of anticoagulant activities of drugs during the period. The problem is compounded and assumes the highest order of significance since two lives are involved and all the investigations and management done should also take into account the potential adverse effects on the foetus. In order to prevent the development of VTE during pregnancy, sound clinical evaluation for risk factors, risk stratification, and optimal use of resource both mechanical and pharmacological is necessary. This paper details strategies in preventing development of deep vein thrombosis and treatment of VTEs.

Citing Articles

Management of Acute Saddle Pulmonary Embolism in Pregnancy Following Fetal Surgery.

Connell P, Marquez Roa L, Araujo-Duran J, Cheriyan M, Ayad S Cureus. 2024; 16(2):e54607.

PMID: 38523954 PMC: 10959467. DOI: 10.7759/cureus.54607.

Venous Thromboembolism in Pregnancy: Challenges and Solutions.

Varrias D, Spanos M, Kokkinidis D, Zoumpourlis P, Kalaitzopoulos D Vasc Health Risk Manag. 2023; 19:469-484.

PMID: 37492280 PMC: 10364824. DOI: 10.2147/VHRM.S404537.

Maternal mortality following thromboembolism; incidences and prophylaxis strategies.

Shirazi M, Sahebdel B, Torkzaban M, Feizabad E, Ghaemi M Thromb J. 2020; 18(1):36.

PMID: 33292311 PMC: 7708248. DOI: 10.1186/s12959-020-00251-w.

Physical Exertion Immediately Prior to Placental Abruption: A Case-Crossover Study.

Chahal H, Gelaye B, Mostofsky E, Sanchez S, Mittleman M, MacLure M Am J Epidemiol. 2018; 187(10):2073-2079.

PMID: 29992226 PMC: 6194205. DOI: 10.1093/aje/kwy138.

A Unique Recombinant Fluoroprobe Targeting Activated Platelets Allows Detection of Arterial Thrombosis and Pulmonary Embolism Using a Novel Three-Dimensional Fluorescence Emission Computed Tomography (FLECT) Technology.

Lim B, Yao Y, Huang A, Yap M, Flierl U, Palasubramaniam J Theranostics. 2017; 7(5):1047-1061.

PMID: 28435447 PMC: 5399575. DOI: 10.7150/thno.18099.

References

Verdonkschot A, Vasmel W, Middeldorp S, van der Schoot J . Skin reactions due to low molecular weight heparin in pregnancy: a strategic dilemma. Arch Gynecol Obstet. 2004; 271(2):163-5. DOI: 10.1007/s00404-004-0615-0. View

Lindqvist P, Dahlback B, Marsal K . Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999; 94(4):595-9. DOI: 10.1016/s0029-7844(99)00308-7. View

Chung I, Lip G . Virchow's triad revisited: blood constituents. Pathophysiol Haemost Thromb. 2005; 33(5-6):449-54. DOI: 10.1159/000083844. View

Forestier F, Daffos F . Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res. 1984; 34(6):557-60. DOI: 10.1016/0049-3848(84)90260-3. View

Wesseling J, Van Driel D, Heymans H, Rosendaal F, Smrkovsky M, Touwen B . Coumarins during pregnancy: long-term effects on growth and development of school-age children. Thromb Haemost. 2001; 85(4):609-13. View

Polak J, Wilkinson D . Ultrasonographic diagnosis of symptomatic deep venous thrombosis in pregnancy. Am J Obstet Gynecol. 1991; 165(3):625-9. DOI: 10.1016/0002-9378(91)90297-5. View

Kearon C, Julian J, Newman T, Ginsberg J . Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med. 1998; 128(8):663-77. DOI: 10.7326/0003-4819-128-8-199804150-00011. View

Nishii A, Noda Y, Nemoto R, Ushiro K, Ohno T, Mochizuki Y . Evaluation of D-dimer during pregnancy. J Obstet Gynaecol Res. 2009; 35(4):689-93. DOI: 10.1111/j.1447-0756.2008.01007.x. View

Bates S, Greer I, Pabinger I, Sofaer S, Hirsh J . Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl):844S-886S. DOI: 10.1378/chest.08-0761. View

10.

James A . Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009; 29(3):326-31. DOI: 10.1161/ATVBAHA.109.184127. View

11.

Macklon N, Greer I . The deep venous system in the puerperium: an ultrasound study. Br J Obstet Gynaecol. 1997; 104(2):198-200. DOI: 10.1111/j.1471-0528.1997.tb11044.x. View

12.

Turkstra F, Kuijer P, van Beek E, Brandjes D, Ten Cate J, Buller H . Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism. Ann Intern Med. 1997; 126(10):775-81. DOI: 10.7326/0003-4819-126-10-199705150-00005. View

13.

To M, Hunt B, Nelson-Piercy C . A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy. J Obstet Gynaecol. 2008; 28(2):222-3. DOI: 10.1080/01443610801915975. View

14.

Nijkeuter M, Huisman M . Diagnosing pulmonary embolism in pregnancy: Is there a role for D-dimer as a stand-alone test?. Crit Care Med. 2006; 34(10):2701. DOI: 10.1097/01.CCM.0000240786.73945.9F. View

15.

Leyh R, Fischer S, Ruhparwar A, Haverich A . Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative?. Eur J Cardiothorac Surg. 2002; 21(3):577-9. DOI: 10.1016/s1010-7940(01)01154-x. View

16.

Scott K, Rutherford N, Fagermo N, Lust K . Use of imaging for investigation of suspected pulmonary embolism during pregnancy and the postpartum period. Obstet Med. 2016; 4(1):20-3. PMC: 4989656. DOI: 10.1258/om.2010.100065. View

17.

Lee H, Cho S, Lee H, Kim C, Park J, Chi J . Warfarin-associated fetal intracranial hemorrhage: a case report. J Korean Med Sci. 2003; 18(5):764-7. PMC: 3055110. DOI: 10.3346/jkms.2003.18.5.764. View

18.

Sanson B, Lensing A, Prins M, Ginsberg J, Barkagan Z, Lavenne-Pardonge E . Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost. 1999; 81(5):668-72. View

19.

Marik P, Plante L . Venous thromboembolic disease and pregnancy. N Engl J Med. 2008; 359(19):2025-33. DOI: 10.1056/NEJMra0707993. View

20.

Gerhardt A, Zotz R, Stockschlaeder M, Scharf R . Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Thromb Haemost. 2007; 97(3):496-7. View